154 related articles for article (PubMed ID: 2142011)
1. Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome.
Flament S; Delacourte A; Mann DM
Brain Res; 1990 May; 516(1):15-9. PubMed ID: 2142011
[TBL] [Abstract][Full Text] [Related]
2. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
[TBL] [Abstract][Full Text] [Related]
3. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process.
Flament S; Delacourte A
FEBS Lett; 1989 Apr; 247(2):213-6. PubMed ID: 2497028
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages.
Mann DM; Prinja D; Davies CA; Ihara Y; Delacourte A; Défossez A; Mayer RJ; Landon M
J Neurol Sci; 1989 Sep; 92(2-3):247-60. PubMed ID: 2553874
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
Flament S; Delacourte A; Verny M; Hauw JJ; Javoy-Agid F
Acta Neuropathol; 1991; 81(6):591-6. PubMed ID: 1831952
[TBL] [Abstract][Full Text] [Related]
6. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Joachim CL; Morris JH; Kosik KS; Selkoe DJ
Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
[TBL] [Abstract][Full Text] [Related]
7. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two pathological tau protein, variants in Alzheimer brain cortices.
Flament S; Delacourte A; Hémon B; Défossez A
J Neurol Sci; 1989 Sep; 92(2-3):133-41. PubMed ID: 2509637
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.
Delacourte A; Defossez A
J Neurol Sci; 1986 Dec; 76(2-3):173-86. PubMed ID: 3098926
[TBL] [Abstract][Full Text] [Related]
11. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
[TBL] [Abstract][Full Text] [Related]
12. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
13. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.
Goedert M; Spillantini MG; Cairns NJ; Crowther RA
Neuron; 1992 Jan; 8(1):159-68. PubMed ID: 1530909
[TBL] [Abstract][Full Text] [Related]
14. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.
Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH
Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184
[TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical and lectin histochemical studies of plaques and tangles in Down's syndrome patients at different ages.
Mann DM; Brown A; Wilks DP; Davies CA
Prog Clin Biol Res; 1989; 317():849-56. PubMed ID: 2532371
[TBL] [Abstract][Full Text] [Related]
17. Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.
Flament S; Delacourte A; Delaère P; Duyckaerts C; Hauw JJ
Acta Neuropathol; 1990; 80(2):212-5. PubMed ID: 2117842
[TBL] [Abstract][Full Text] [Related]
18. Along the way to a neurofibrillary tangle: a look at the structure of tau.
Kosik KS; Kowall NW; McKee A
Ann Med; 1989; 21(2):109-12. PubMed ID: 2504256
[TBL] [Abstract][Full Text] [Related]
19. Alz-50 recognizes a phosphorylated epitope of tau protein.
Uéda K; Masliah E; Saitoh T; Bakalis SL; Scoble H; Kosik KS
J Neurosci; 1990 Oct; 10(10):3295-304. PubMed ID: 1698946
[TBL] [Abstract][Full Text] [Related]
20. Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.
Liang Z; Liu F; Iqbal K; Grundke-Iqbal I; Wegiel J; Gong CX
J Alzheimers Dis; 2008 Apr; 13(3):295-302. PubMed ID: 18430997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
